Abstract
Introduction
The influence of sex and gender is particularly relevant in cardiovascular diseases (CVD) as well as in several aspects of drug pharmacodynamics and pharmacokinetics. Anatomical and physiological differences between the sexes may influence the activity of many drugs, including the possibility of their interaction with other drugs, bioactive compounds, foods and beverages. Phenolic compounds could interact with our organism at organ, cellular, and molecular levels triggering a preventive action against chronic diseases, including CVD.
Results
This article will review the role of sex on the activity of these bioactive molecules, considering the existence of sex differences in oxidative stress. It describes the pharmacokinetics of phenolic compounds, their effects on vessels, on cardiovascular system, and during development, including the role of nuclear receptors and microbiota.
Conclusions
Although there is a large gap between the knowledge of the sex differences in the phenolic compounds’ activity and safety, and the urgent need for more research, available data underlie the possibility that plant-derived phenolic compounds could differently influence the health of male and female subjects.
Similar content being viewed by others
References
Legato MJ, Johnson PA, Manson JE (2016) Consideration of sex differences in medicine to improve health care and patient outcomes. JAMA 316(18):1865–1866
Agabio R, Pisanu C, Gessa GL, Franconi F (2016) Sex differences in alcohol use disorder. Curr Med Chem 24:2661–2670
Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V (2016) Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 37(1):24–34
Kander MC, Cui Y, Liu Z (2016) Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med:1024–1032
Franconi F, Campesi I (2014) Sex and gender influences on pharmacological response: an overview. Expert Rev Clin Pharmacol 7(4):469–485
Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F (2011) Nutrition and human health from a sex-gender perspective. Mol Asp Med 32(1):1–70
Lemire J, Alhasawi A, Appanna VP, Tharmalingam S, Appanna VD (2017) Metabolic defense against oxidative stress: the road less travelled-so far. J Appl Microbiol 173:798–809
Malorni W, Campesi I, Straface E, Vella S, Franconi F (2007) Redox features of the cell: a gender perspective. Antioxid Redox Signal 9(11):1779–1801
Franconi F, Rosano G, Basili S, Montella A, Campesi I (2017) Human cells involved in atherosclerosis have a sex. Int J Cardiol 228:983–1001
Egea J, Fabregat I, Frapart YM, Ghezzi P, Gorlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertran E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Forstermann U, Giniatullin R, Giricz Z, Gorbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustin P, Hillion M, Huang J, Ilikay S, Jansen-Durr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kracun D, Krause KH, Kren V, Krieg T, Laranjinha J, Lazou A, Li H, Martinez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milkovic L, Miranda-Vizuete A, Mojovic M, Monsalve M, Mouthuy PA, Mulvey J, Munzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavicevic A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Anton N, Rodriguez-Manas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schroder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanic V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentova K, Van Breusegem F, Varisli L, Veal EA, Yalcin AS, Yelisyeyeva O, Zarkovic N, Zatloukalova M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt H, Di Lisa F, Daiber A (2017) European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 13:94–162
Ritchie RH, Drummond GR, Sobey CG, De Silva TM, Kemp-Harper BK (2017) The opposing roles of NO and oxidative stress in cardiovascular disease. Pharmacol Res 116:57–69
Holmstrom KM, Finkel T (2014) Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 15(6):411–421
Jaiswal AK (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36(10):1199–1207
Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, Park BJ (2013) Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 346:f10
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361(9374):2017–2023
Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18(14):1818–1892
Rodriguez-Mateos A, Vauzour D, Krueger CG, Shanmuganayagam D, Reed J, Calani L, Mena P, Del Rio D, Crozier A (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol 88(10):1803–1853
Cueva C, Gil-Sanchez I, Ayuda-Duran B, Gonzalez-Manzano S, Gonzalez-Paramas AM, Santos-Buelga C, Bartolome B, Moreno-Arribas MV (2017) An integrated view of the effects of wine polyphenols and their relevant metabolites on gut and host health. Molecules 22(1):99
Virgili F, Marino M (2008) Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med 45(9):1205–1216
Pandjaitan N, Hettiarachchy N, Ju ZY, Crandall P, Sneller C, Dombek D (2000) Evaluation of genistin and genistein contents in soybean varieties and soy protein concentrate prepared with three basic methods. J Food Sci 65:399–402
Marcoccia D, Pellegrini M, Fiocchetti M, Lorenzetti S, Marino M (2017) Food components and contaminants as (anti)androgenic molecules. Genes Nutr 12:6
Woodside JV, Young IS, McKinley MC (2013) Fruit and vegetable intake and risk of cardiovascular disease. Proc Nutr Soc 72(4):399–406
Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349:g4490
Rangel-Huerta OD, Pastor-Villaescusa B, Aguilera CM, Gil A (2015) A systematic review of the efficacy of bioactive compounds in cardiovascular disease: phenolic compounds. Nutrients 7(7):5177–5216
Anthony MS, Clarkson TB, Bullock BC, Wagner JD (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17(11):2524–2531
Chong MF, Macdonald R, Lovegrove JA (2010) Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr 104(Suppl 3):S28–S39
Alissa EM, Ferns GA (2017) Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr 57(9):1950–1962
Guo Y, Bruno RS (2015) Endogenous and exogenous mediators of quercetin bioavailability. J Nutr Biochem 26(3):201–210
González-Sarrías A, Combet E, Pinto P, Mena P, Dall’Asta M, Garcia-Aloy M, Rodríguez-Mateos A, Gibney ER, Dumont J, Massaro M, Sánchez-Meca J, Morand C, García-Conesa MT (2017) A systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on body composition and blood lipids: exploring the factors responsible for variability in their efficacy. Nutrients 9:746
Campesi I, Romani A, Marino M, Franconi F (2014) Phenolic compounds from a sex-gender perspective. In: Romani A, Lattanzio S, Quideau S (eds) Recent advances in polyphenol research. Wiley, Chichester, pp 327–339
Quideau S, Deffieux D, Douat-Casassus C, Pouysegu L (2011) Plant polyphenols: chemical properties, biological activities, and synthesis. Angew Chem Int Ed Engl 50(3):586–621
Galluzzo P, Marino M (2006) Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities. Genes Nutr 1(3–4):161–176
Walle T, Browning AM, Steed LL, Reed SG, Walle UK (2005) Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 135(1):48–52
Marin L, Miguelez EM, Villar CJ, Lombo F (2015) Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int 2015:905215
Gee JM, DuPont MS, Day AJ, Plumb GW, Williamson G, Johnson IT (2000) Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 130(11):2765–2771
Franconi F, Brunelleschi S, Steardo L, Cuomo V (2007) Gender differences in drug responses. Pharmacol Res 55(2):81–95
Franconi F, Chessa MS,ES, Rosano R G (2011) Pharmacokinetics and pharmacodynamics: the role of sex and gender. In: Oertelt-Prigione S, Regitz-Zagrosek V (eds) Sex and gender aspects in clinical medicine. Springer, London, pp 183–194
Gerbal-Chaloin S, Iankova I, Maurel P, Daujat-Chavanieu M (2013) Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metab Rev 45(1):122–144
Petrick JS, Klaassen CD (2007) Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab Dispos 35(10):1806–1815
Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG (2003) Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 307(3):906–922
Ekstrand B, Rasmussen MK, Woll F, Zlabek V, Zamaratskaia G (2015) In vitro gender-dependent inhibition of porcine cytochrome p450 activity by selected flavonoids and phenolic acids. Biomed Res Int 2015:387918
Ostlund J, Zlabek V, Zamaratskaia G (2017) In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent. Toxicology 381:10–18
Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML (2009) Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr 139(5):898–904
Wahajuddin SN, Taneja I, Arora S, Raju KS, Siddiqui N (2013) Disposition of pharmacologically active dietary isoflavones in biological systems. Curr Drug Metab 14(4):369–380
Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35(1):35–98
Soukup ST, Helppi J, Muller DR, Zierau O, Watzl B, Vollmer G, Diel P, Bub A, Kulling SE (2016) Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison. Arch Toxicol 90(6):1335–1347
Strassburg CP, Kalthoff S, Ehmer U (2008) Variability and function of family 1 uridine-5′-diphosphate glucuronosyltransferases (UGT1A). Crit Rev Clin Lab Sci 45(6):485–530
Saracino MR, Bigler J, Schwarz Y, Chang JL, Li S, Li L, White E, Potter JD, Lampe JW (2009) Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism. J Nutr 139(3):555–560
Navarro SL, Peterson S, Chen C, Makar KW, Schwarz Y, King IB, Li SS, Li L, Kestin M, Lampe JW (2009) Cruciferous vegetable feeding alters UGT1A1 activity: diet- and genotype-dependent changes in serum bilirubin in a controlled feeding trial. Cancer Prev Res (Phila) 2(4):345–352
Saracino MR, Lampe JW (2007) Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 59(2):121–141
Zhang Y, Klein K, Sugathan A, Nassery N, Dombkowski A, Zanger UM, Waxman DJ (2011) Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease. PLoS One 6(8):e23506
Matthews J, Wihlen B, Thomsen J, Gustafsson JA (2005) Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol 25(13):5317–5328
Monostory K, Pascussi JM, Kobori L, Dvorak Z (2009) Hormonal regulation of CYP1A expression. Drug Metab Rev 41(4):547–572
Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S (2003) Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423(6939):545–550
Runge-Morris M, Kocarek TA, Falany CN (2013) Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab Rev 45(1):15–33
Alnouti Y, Klaassen CD (2011) Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Xenobiotica 41(3):187–197
Yang CH, Tang L, Lv C, Ye L, Xia BJ, Hu M, Liu ZQ (2011) Sulfation of selected mono-hydroxyflavones by sulfotransferases in vitro: a species and gender comparison. J Pharm Pharmacol 63(7):967–970
Wang P, Heber D, Henning SM (2012) Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct 3(6):635–642
Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727–747
Hong YJ, Mitchell AE (2004) Metabolic profiling of flavonol metabolites in human urine by liquid chromatography and tandem mass spectrometry. J Agric Food Chem 52(22):6794–6801
Mitchell AE, Burns SA, Rudolf JL (2007) Isozyme- and gender-specific induction of glutathione S-transferases by flavonoids. Arch Toxicol 81(11):777–784
Igarashi T, Satoh T, Ueno K, Kitagawa H (1983) Sex-related difference in the hepatic glutathione level and related enzyme activities in rat. J Biochem 93(1):33–36
Donovan JL, Manach C, Faulks RM, Kroon PA (2006) Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashihara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Wiley Online Library, Hoboken, pp 303–351
Wiseman H, Casey K, Bowey EA, Duffy R, Davies M, Rowland IR, Lloyd AS, Murray A, Thompson R, Clarke DB (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80(3):692–699
Lu YF, Jin T, Xu Y, Zhang D, Wu Q, Zhang YK, Liu J (2013) Sex differences in the circadian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver. Chronobiol Int 30(9):1135–1143
Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223(1–2):9–22
Gradolatto A, Basly JP, Berges R, Teyssier C, Chagnon MC, Siess MH, Canivenc-Lavier MC (2005) Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 33(1):49–54
Wruss J, Lanzerstorfer P, Huemer S, Himmelsbach M, Mangge H, Hoglinger O, Weghuber D, Weghuber J (2015) Differences in pharmacokinetics of apple polyphenols after standardized oral consumption of unprocessed apple juice. Nutr J 14:32–42
Lu LJ, Anderson KE (1998) Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68(6 Suppl):1500S–1504S
Faughnan MS, Hawdon A, Ah-Singh E, Brown J, Millward DJ, Cassidy A (2004) Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br J Nutr 91(4):567–574
Milenkovic D, Morand C, Cassidy A, Konic-Ristic A, Tomas-Barberan F, Ordovas JM, Kroon P, De Caterina R, Rodriguez-Mateos A (2017) Interindividual variability in biomarkers of cardiometabolic health after consumption of major plant-food bioactive compounds and the determinants involved. Adv Nutr 8(4):558–570
Manach C, Milenkovic D, Van de Wiele T, Rodriguez-Mateos A, de Roos B, Garcia-Conesa MT, Landberg R, Gibney ER, Heinonen M, Tomas-Barberan F, Morand C (2017) Addressing the inter-individual variation in response to consumption of plant food bioactives: towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Mol Nutr Food Res 61:(6)
Sureda A, Sanches Silva A, Sanchez-Machado DI, Lopez-Cervantes J, Daglia M, Nabavi SF, Nabavi SM (2017) Hypotensive effects of genistein: from chemistry to medicine. Chem Biol Interact 268:37–46
Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, Andrica F, Ahmed A, Aronow WS, Muntner P, Lip GY, Graham I, Wong N, Rysz J, Banach M (2016) Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 5(7):e00273
Al-Nakkash L, Martin JB, Petty D, Lynch SM, Hamrick C, Lucy D, Robinson J, Peterson A, Rubin LJ, Broderick TL (2012) Dietary genistein induces sex-dependent effects on murine body weight, serum profiles, and vascular function of thoracic aortae. Gend Med 9(5):295–308
Peroni RN, Abramoff T, Neuman I, Podesta EJ, Adler-Graschinsky E (2012) Phytoestrogens enhance the vascular actions of the endocannabinoid anandamide in mesenteric beds of female rats. Int J Hypertens 2012:647856
Kane MO, Anselm E, Rattmann YD, Auger C, Schini-Kerth VB (2009) Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols. Vascul Pharmacol 51(2–3):140–146
Finking G, Wohlfrom M, Lenz C, Wolkenhauer M, Eberle C, Hanke H (1999) The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury. Coron Artery Dis 10(8):607–615
Menezes R, Rodriguez-Mateos A, Kaltsatou A, Gonzalez-Sarrias A, Greyling A, Giannaki C, Andres-Lacueva C, Milenkovic D, Dumont ER, Schar M, Garcia-Aloy M, Palma-Duran SA, Ruskovska T, Maksimova V, Combet E, Pinto P (2017) Impact of flavonols on cardiometabolic biomarkers: a meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. Nutrients 9(2):117
Macready AL, George TW, Chong MF, Alimbetov DS, Jin Y, Vidal A, Spencer JP, Kennedy OB, Tuohy KM, Minihane AM, Gordon MH, Lovegrove JA (2014) Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease—FLAVURS: a randomized controlled trial. Am J Clin Nutr 99(3):479–489
Mennen LI, Sapinho D, de Bree A, Arnault N, Bertrais S, Galan P, Hercberg S (2004) Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr 134(4):923–926
Setchell KD, Clerici C (2010) Equol: pharmacokinetics and biological actions. J Nutr 140(7):1363S–1368S
Setchell KD, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132(12):3577–3584
Hazim S, Curtis PJ, Schar MY, Ostertag LM, Kay CD, Minihane AM, Cassidy A (2016) Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr 103(3):694–702
Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G (2008) The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 392(1–2):1–7
Cheatham CL, Vazquez-Vidal I, Medlin A, Voruganti VS (2016) Blueberry consumption affects serum uric acid concentrations in older adults in a sex-specific manner. Antioxidants (Basel) 5 (4)
Ostertag LM, Kroon PA, Wood S, Horgan GW, Cienfuegos-Jovellanos E, Saha S, Duthie GG, de Roos B (2013) Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way—a randomized-controlled human intervention trial. Mol Nutr Food Res 57(2):191–202
Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, Wolffram S, Muller MJ (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102(7):1065–1074
Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T (2007) Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137(11):2405–2411
Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L (2013) Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med 4(7):777–785
Alonso A, Martinez-Gonzalez MA (2004) Olive oil consumption and reduced incidence of hypertension: the SUN study. Lipids 39(12):1233–1238
Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K (2003) Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Prev Med 36(6):692–697
Rivas M, Garay RP, Escanero JF, Cia P Jr, Cia P, Alda JO (2002) Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132(7):1900–1902
Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86(7):3053–3060
Liang YL, Teede H, Dalais F, McGrath BP (2006) The effects of phytoestrogen on blood pressure and lipids in healthy volunteers. Zhonghua Xin Xue Guan Bing Za Zhi 34(8):726–729
Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD (2008) Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88(4):1018–1025
Ho SC, Woo JL, Leung SS, Sham AL, Lam TH, Janus ED (2000) Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 130(10):2590–2593
Li SH, Liu XX, Bai YY, Wang XJ, Sun K, Chen JZ, Hui RT (2010) Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 91(2):480–486
Beavers DP, Beavers KM, Miller M, Stamey J, Messina MJ (2012) Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 22(3):182–191
Liew R, Stagg MA, Chan J, Collins P, MacLeod KT (2004) Gender determines the acute actions of genistein on intracellular calcium regulation in the guinea-pig heart. Cardiovasc Res 61(1):66–76
Olsson MC, Palmer BM, Leinwand LA, Moore RL (2001) Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 280(3):H1136-1144
Vikstrom KL, Factor SM, Leinwand LA (1996) Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 2(5):556–567
Haines CD, Harvey PA, Leinwand LA (2012) Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology 153(9):4480–4490
Haines CD, Harvey PA, Luczak ED, Barthel KK, Konhilas JP, Watson PA, Stauffer BL, Leinwand LA (2012) Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology 153(9):4470–4479
Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA (2006) Soy diet worsens heart disease in mice. J Clin Investig 116(1):209–216
Konhilas JP, Chen H, Luczak E, McKee LA, Regan J, Watson PA, Stauffer BL, Khalpey ZI, McKinsey TA, Horn T, LaFleur B, Leinwand LA (2015) Diet and sex modify exercise and cardiac adaptation in the mouse. Am J Physiol Heart Circ Physiol 308(2):H135-145
Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M (2006) Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee. Arterioscler Thromb Vasc Biol 26(8):1689–1692
van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE (2005) Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111(4):465–471
Maskarinec G, Aylward AG, Erber E, Takata Y, Kolonel LN (2008) Soy intake is related to a lower body mass index in adult women. Eur J Nutr 47(3):138–144
Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333(5):276–282
Welty FK, Lee KS, Lew NS, Zhou JR (2007) Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 167(10):1060–1067
Nagata C, Takatsuka N, Kurisu Y, Shimizu H (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 128(2):209–213
Cheng SY, Shaw NS, Tsai KS, Chen CY (2004) The hypoglycemic effects of soy isoflavones on postmenopausal women. J Women’s Health (Larchmt) 13(10):1080–1086
Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willett WC (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85(3):735–741
Zamora-Ros R, Jimenez C, Cleries R, Agudo A, Sanchez MJ, Sanchez-Cantalejo E, Molina-Montes E, Navarro C, Chirlaque MD, Maria Huerta J, Amiano P, Redondo ML, Barricarte A, Gonzalez CA (2013) Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology 24(5):726–733
Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F, Zheng W (2003) Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133(9):2874–2878
Yu D, Zhang X, Xiang YB, Yang G, Li H, Fazio S, Linton M, Cai Q, Zheng W, Gao YT, Shu XO (2014) Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. Int J Cardiol 172(2):e285–e287
Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 116(22):2553–2562
Nagata C, Takatsuka N, Shimizu H (2002) Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol 156(9):824–831
Talaei M, Koh WP, van Dam RM, Yuan JM, Pan A (2014) Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr 144(6):921–928
Lou D, Li Y, Yan G, Bu J, Wang H (2016) Soy consumption with risk of coronary heart disease and stroke: a meta-analysis of observational studies. Neuroepidemiology 46(4):242–252
Hollman PC, Geelen A, Kromhout D (2010) Dietary flavonol intake may lower stroke risk in men and women. J Nutr 140(3):600–604
Giergiel M, Lopucki M, Stachowicz N, Kankofer M (2012) The influence of age and gender on antioxidant enzyme activities in humans and laboratory animals. Aging Clin Exp Res 24(6):561–569
Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626–638
Fairweather D (2014) Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol 8(Suppl 3):49–59
Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Bello-Klein A, Singal P (2002) Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz J Med Biol Res 35(9):1075–1081
Morales RC, Bahnson ES, Havelka GE, Cantu-Medellin N, Kelley EE, Kibbe MR (2015) Sex-based differential regulation of oxidative stress in the vasculature by nitric oxide. Redox Biol 4:226–233
Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C, Conti F, Riccieri V, Rosano G, Ortona E, Malorni W (2011) Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells. Antioxid Redox Signal 15(11):2825–2836
Straface E, Vona R, Gambardella L, Ascione B, Marino M, Bulzomi P, Canu S, Coinu R, Rosano G, Malorni W, Franconi F (2009) Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett 583(21):3448–3454
Malorni W, Straface E, Matarrese P, Ascione B, Coinu R, Canu S, Galluzzo P, Marino M, Franconi F (2008) Redox state and gender differences in vascular smooth muscle cells. FEBS Lett 582(5):635–642
Chen Y, Ji LL, Liu TY, Wang ZT (2011) Evaluation of gender-related differences in various oxidative stress enzymes in mice. Chin J Physiol 54(6):385–390
Kayali R, Cakatay U, Uzun H, Genc H (2007) Gender difference as regards myocardial protein oxidation in aged rats: male rats have increased oxidative protein damage. Biogerontology 8(6):653–661
Campesi I, Straface E, Occhioni S, Montella A, Franconi F (2013) Protein oxidation seems to be linked to constitutive autophagy: a sex study. Life Sci 93(4):145–152
Horvathova M, Zitnanova I, Kralovicova Z, Balis P, Puzserova A, Muchova J, Kluknavsky M, Durackova Z, Bernatova I (2016) Sex differences in the blood antioxidant defense system in juvenile rats with various genetic predispositions to hypertension. Hypertens Res 39(2):64–69
Fortepiani LA, Reckelhoff JF (2005) Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats. J Hypertens 23(4):801–805
Miller AA, Drummond GR, Mast AE, Schmidt HH, Sobey CG (2007) Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke 38(7):2142–2149
Zhang R, Thor D, Han X, Anderson L, Rahimian R (2012) Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs. Am J Physiol Heart Circ Physiol 303(10):H1183-1198
Ali SS, Xiong C, Lucero J, Behrens MM, Dugan LL, Quick KL (2006) Gender differences in free radical homeostasis during aging: shorter-lived female C57BL6 mice have increased oxidative stress. Aging Cell 5(6):565–574
Dai G, He L, Chou N, Wan YJ (2006) Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse. Toxicol Sci 92(1):33–41
Masubuchi Y, Nakayama J, Watanabe Y (2011) Sex difference in susceptibility to acetaminophen hepatotoxicity is reversed by buthionine sulfoximine. Toxicology 287(1–3):54–60
Pellegrini GG, Cregor M, McAndrews K, Morales CC, McCabe LD, McCabe GP, Peacock M, Burr D, Weaver C, Bellido T (2017) Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age. PLoS One 12(2):e0171161
Yu J, Zhao Y, Li B, Sun L, Huo H (2012) 17beta-estradiol regulates the expression of antioxidant enzymes in myocardial cells by increasing Nrf2 translocation. J Biochem Mol Toxicol 26(7):264–269
Addis R, Campesi I, Fois M, Capobianco G, Dessole S, Fenu G, Montella A, Cattaneo MG, Vicentini LM, Franconi F (2014) Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biol Sex Differ 5(1):18
Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22(3):438–442
Brunelli E, Domanico F, La Russa D, Pellegrino D (2014) Sex differences in oxidative stress biomarkers. Curr Drug Targets 15(8):811–815
Tothova L, Ostatnikova D, Sebekova K, Celec P, Hodosy J (2013) Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva. Ann Hum Biol 40(2):175–180
Campesi I, Occhioni S, Tonolo G, Cherchi S, Basili S, Carru C, Zinellu A, Franconi F (2016) Ageing/menopausal status in healthy women and ageing in healthy men differently affect cardiometabolic parameters. Int J Med Sci 13(2):124–132
Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, Vidry S (2011) The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 141(5):989S–1009S
Halliwell B (2007) Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res 73(2):341–347
Ambrosini G, Romani A, Scazzocchio B, Varì R, Vona R, Campesi I, Banelli L, Straface E, Masella R, Malorni W, Franconi F (2012) Sex-gender influences the expression of antioxidant/detoxifying enzyme induced by extra rirgin olive oil extracts in rat vascular smooth muscle cells. In: XXVIth international conference on polyphenols 22–26 July 2012, Florence Italy 2012, pp 437–438
Kamper EF, Chatzigeorgiou A, Tsimpoukidi O, Kamper M, Dalla C, Pitychoutis PM, Papadopoulou-Daifoti Z (2009) Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiol Behav 98(1–2):215–222
Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavailles V, Balaguer P (2006) Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 71(10):1459–1469
Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80(1):14–25
Acconcia F, Fiocchetti M, Marino M (2016) Xenoestrogen regulation of ERalpha/ERbeta balance in hormone-associated cancers. Mol Cell Endocrinol 457:3–12
Pellegrini M, Bulzomi P, Lecis M, Leone S, Campesi I, Franconi F, Marino M (2014) Endocrine disruptors differently influence estrogen receptor beta and androgen receptor in male and female rat VSMC. J Cell Physiol 229(8):1061–1068
Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Krogh Pedersen H, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Igor Costea P, Kultima JR, Li J, Jorgensen T, Levenez F, Dore J, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528(7581):262–266
Tang WH, Hazen SL (2014) The contributory role of gut microbiota in cardiovascular disease. J Clin Investig 124(10):4204–4211
Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, Wagner MA, Bennett BJ, Li L, DiDonato JA, Lusis AJ, Hazen SL (2015) Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 290(9):5647–5660
Aron-Wisnewsky J, Clement K (2016) The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol 12(3):169–181
Burrows MP, Volchkov P, Kobayashi KS, Chervonsky AV (2015) Microbiota regulates type 1 diabetes through Toll-like receptors. Proc Natl Acad Sci USA 112(32):9973–9977
Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health: a review. Brain Behav Immun 66:9–17
Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14(1):20–32
Salazar N, Arboleya S, Valdes L, Stanton C, Ross P, Ruiz L, Gueimonde M, de CG Los Reyes-Gavilan (2014) The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet 5:406
Kaplan H, Hill K, Lancaster J, Hurtado AM (2000) A theory of human life history evolution: diet, intelligence, and longevity. Evol Anthropol 9:156–185
Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Org E, Parks B, Lusis AJ, Knight R, Caporaso JG, Svanback R (2014) Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun 5:4500
Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F (2010) Nutrition and human health from a sex-gender perspective. Mol Asp Med 32(1):1–70
Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339(6123):1084–1088
Dominianni C, Sinha R, Goedert JJ, Pei Z, Yang L, Hayes RB, Ahn J (2015) Sex, body mass index, and dietary fiber intake influence the human gut microbiome. PLoS One 10(4):e0124599
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222–227
Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X, Zhang M, Wei H, Chen Y, Lu H, Zuo J, Su M, Qiu Y, Jia W, Xiao C, Smith LM, Yang S, Holmes E, Tang H, Zhao G, Nicholson JK, Li L, Zhao L (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105(6):2117–2122
Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Dore J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027–1033
Haro C, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Landa BB, Navas-Cortes JA, Tena-Sempere M, Clemente JC, Lopez-Miranda J, Perez-Jimenez F, Camargo A (2016) Intestinal microbiota is influenced by gender and body mass index. PLoS One 11(5):e0154090
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, Backhed F, Isolauri E, Salminen S, Ley RE (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150(3):470–480
Espin JC, Gonzalez-Sarrias A, Tomas-Barberan FA (2017) The gut microbiota: a key factor in the therapeutic effects of (poly)phenols. Biochem Pharmacol 139:82–93
Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E (2016) The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 8(2):78–113
Frankenfeld CL, Atkinson C, Wahala K, Lampe JW (2014) Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur J Clin Nutr 68(4):526–530
Nakatsu CH, Armstrong A, Clavijo AP, Martin BR, Barnes S, Weaver CM (2014) Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS One 9(10):e108924
Usui T, Tochiya M, Sasaki Y, Muranaka K, Yamakage H, Himeno A, Shimatsu A, Inaguma A, Ueno T, Uchiyama S, Satoh-Asahara N (2013) Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol (Oxf) 78(3):365–372
Ridlon JM, Ikegawa S, Alves JM, Zhou B, Kobayashi A, Iida T, Mitamura K, Tanabe G, Serrano M, De Guzman A, Cooper P, Buck GA, Hylemon PB (2013) Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res 54(9):2437–2449
Balakrishnan B, Thorstensen EB, Ponnampalam AP, Mitchell MD (2010) Transplacental transfer and biotransformation of genistein in human placenta. Placenta 31(6):506–511
Foster WG, Chan S, Platt L, Hughes CL Jr (2002) Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 129(3):199–205
Soucy NV, Parkinson HD, Sochaski MA, Borghoff SJ (2006) Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 90(1):230–240
Jarrell J, Foster WG, Kinniburgh DW (2012) Phytoestrogens in human pregnancy. Obstet Gynecol Int 2012:850313
Diaz-Castro J, Pulido-Moran M, Moreno-Fernandez J, Kajarabille N, de Paco C, Garrido-Sanchez M, Prados S, Ochoa JJ (2016) Gender specific differences in oxidative stress and inflammatory signaling in healthy term neonates and their mothers. Pediatr Res 80(4):595–601
Hanson MA, Gluckman PD (2008) Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol 102(2):90–93
McCarver G, Bhatia J, Chambers C, Clarke R, Etzel R, Foster W, Hoyer P, Leeder JS, Peters JM, Rissman E, Rybak M, Sherman C, Toppari J, Turner K (2011) NTP-CERHR expert panel report on the developmental toxicity of soy infant formula. Birth Defects Res B Dev Reprod Toxicol 92(5):421–468
Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350(9070):23–27
Strakovsky RS, Lezmi S, Flaws JA, Schantz SL, Pan YX, Helferich WG (2014) Genistein exposure during the early postnatal period favors the development of obesity in female, but not male rats. Toxicol Sci 138(1):161–174
Jefferson WN, Williams CJ (2011) Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes. Reprod Toxicol 31(3):272–279
Jefferson WN, Padilla-Banks E, Goulding EH, Lao SP, Newbold RR, Williams CJ (2009) Neonatal exposure to genistein disrupts ability of female mouse reproductive tract to support preimplantation embryo development and implantation. Biol Reprod 80(3):425–431
Newbold RR, Banks EP, Bullock B, Jefferson WN (2001) Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 61(11):4325–4328
Santti R, Makela S, Strauss L, Korkman J, Kostian ML (1998) Phytoestrogens: potential endocrine disruptors in males. Toxicol Ind Health 14(1–2):223–237
Bulzomi P, Marino M (2011) Environmental endocrine disruptors: does a sex-related susceptibility exist? Front Biosci 16:2478–2498
Acknowledgements
This research was partially funded by a Grant of INAIL “Bando BRIC 2016”.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Campesi, I., Marino, M., Cipolletti, M. et al. Put “gender glasses” on the effects of phenolic compounds on cardiovascular function and diseases. Eur J Nutr 57, 2677–2691 (2018). https://doi.org/10.1007/s00394-018-1695-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-018-1695-0